The Bulletin
The Times


.

Immuno Cure BioTech acquires Shanghai Teresa Healthcare

  • Written by The Bulletin

Integrating Electroporation Technology & DNA Vaccine Platforms

HONG KONG SAR - Media OutReach - 20 September 2022 - Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccines and immunotherapies, announced today the acquisition of 92.6% of Shanghai Teresa Healthcare, the pioneer of electroporation technology and device in China.

Read more: Immuno Cure BioTech acquires Shanghai Teresa Healthcare

hacklink esim balkanzlibraryzlibraryz-libraryFanatikbetjojobethacklink panelmarsbahisvsf watchesjojobetuk casinos not on gamstopGamStopbahis casino siteleri